Treatment Options for Urinary Urgency
Bladder training should be the first-line treatment for urinary urgency, followed by pharmacologic therapy with mirabegron if bladder training is unsuccessful. 1, 2
First-Line Treatments: Non-Pharmacological Approaches
Behavioral Modifications
- Bladder training: Strong recommendation with moderate-quality evidence 1
- Involves scheduled voiding and gradually extending time between voids
- Shown to significantly reduce urgency episodes
Lifestyle Modifications
- Weight loss and exercise: Strong recommendation for obese patients 1
- Fluid management:
- Avoid bladder irritants: 2, 4
Physical Therapy
- Pelvic floor muscle training (PFMT):
Second-Line Treatments: Pharmacological Approaches
If bladder training is unsuccessful, pharmacologic treatment is recommended (strong recommendation, high-quality evidence) 1.
Recommended Medication Algorithm:
First choice: Mirabegron (β3 agonist) 2, 5
- FDA-approved for overactive bladder with symptoms of urge incontinence, urgency, and frequency 5
- Starting dose: 25 mg once daily, may increase to 50 mg after 4-8 weeks if needed 5
- Preferred for patients with risk factors for urinary retention 2
- Does not cause antimuscarinic side effects (dry mouth, constipation)
Second choice: Solifenacin or Darifenacin 2
Last resort: Oxybutynin or Fesoterodine 2
Special Considerations
Dosage Adjustments
- Renal impairment: Reduce mirabegron dose for patients with eGFR <30 mL/min/1.73m² 5
- Hepatic impairment: Reduce mirabegron dose for moderate hepatic impairment; avoid in severe impairment 5
Managing Side Effects
- Constipation: Consider switching to an antimuscarinic with lower constipation risk 2
- Dry mouth: Ensure adequate hydration, sugar-free gum/candy, or consider transdermal formulations 2
- Cognitive concerns: Consider trospium which has lower blood-brain barrier penetration 2
Men with Urinary Urgency
- Consider combination therapy with α-blockers if BPH is present 2, 7
- α-blockers with 5α-reductase inhibitors reduce progression risk to <10% compared to 10-15% with monotherapy 7
Advanced Therapies for Refractory Cases
For patients who fail conservative and pharmacologic treatments:
- Sacral neuromodulation (SNS) 2
- Peripheral tibial nerve stimulation (PTNS) 2
- OnabotulinumtoxinA injections (with counseling about potential self-catheterization) 2
- Consider referral to urology for surgical options 2
Pitfalls to Avoid
- Don't overlook potential infectious causes in women with persistent symptoms; consider doxycycline treatment which has shown 71% effectiveness in some studies 8
- Don't start antimuscarinic therapy without measuring post-void residual volume to minimize urinary retention risk 2
- Avoid high doses of antimuscarinics in elderly patients due to increased risk of cognitive side effects
- Don't ignore fluid intake modification as a simple but effective intervention